Second-hand smoke exposure in homes with children: Assessment of airborne nicotine in the living room and children's bedroom
Por:
Arechavala T., Continente X., Pérez-Ríos M., Schiaffino A., Fernandez E., Cortés-Francisco N., Centrich F., Muñoz G., López M.J.
Publicada:
1 ene 2018
Resumen:
Background The introduction of € smoke-free laws' has reduced the population's exposure to second-hand smoke (SHS), although SHS is still an issue in homes and other public places. Children are vulnerable to its health effects, and their greatest exposure occurs at home. Objectives To assess airborne nicotine concentration of the living room and children's bedroom of homes with children under 13 years of age, and to analyse factors associated with these levels. Methods We conducted a cross-sectional study in Barcelona in 2015-2016, selecting a convenience sample from families with at least one child under 13 years of age. The sample comprised 50 families with smokers and 50 without. We measured airborne nicotine concentrations in the living room and children's bedroom, and, using a questionnaire administered to the parents, collected information about smoking habits at home. Results Homes without smokers showed nicotine concentrations below the limit of detection (<0.02 µg/m 3), while those with at least one smoker showed 0.16 µg/m 3 in the living room and 0.12 µg/m 3 in the bedroom. When smoking was allowed inside home, these values increased to 1.04 and 0.48 µg/m 3, respectively. Moreover, nicotine concentrations in both rooms were strongly correlated (r=0.89), and higher nicotine levels were associated with the number of cigarettes smoked in the living room, smoking rules, the number of smokers living at home and tobacco smell. Conclusions Homes with smokers present SHS in the living room and in the children's bedroom. Therefore, programmes focused on reducing children's SHS exposure are urgently needed. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Filiaciones:
Arechavala T.:
Servei d'Avaluació i Mètodes d'Intervenció, Agència de Salut Publica de Barcelona, Lesseps 1, Barcelona, 08023, Spain
CIBER de Epidemiología y Salud Pública, Madrid, Spain
Department of Experimental and Health Science, Universitat Pompeu Fabra (UPF), Barcelona, Spain
Continente X.:
Servei d'Avaluació i Mètodes d'Intervenció, Agència de Salut Publica de Barcelona, Lesseps 1, Barcelona, 08023, Spain
CIBER de Epidemiología y Salud Pública, Madrid, Spain
Institut d'Investigació Biomèdica Sant Pau (IIB St. Pau), Barcelona, Spain
Pérez-Ríos M.:
Epidemiology Unit, Galician Directorate for Public Health, GalicianHealth Authority, Xunta de Galicia, Spain
Department of Preventive Medicine and Public Health, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
Schiaffino A.:
Direcció General de Planificació en Salut, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
Tobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain
Fernandez E.:
Cancer Prevention and Control Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
Tobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain
Department of Clinical Sciences, Campus de Bellvitge, School of Medicine and Health Science, Universitat de Barcelona, L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain
Cortés-Francisco N.:
Institut d'Investigació Biomèdica Sant Pau (IIB St. Pau), Barcelona, Spain
Laboratori de l'Agència de Salut Pública de Barcelona, Servei de Química, Barcelona, Spain
Centrich F.:
CIBER de Epidemiología y Salud Pública, Madrid, Spain
Institut d'Investigació Biomèdica Sant Pau (IIB St. Pau), Barcelona, Spain
Laboratori de l'Agència de Salut Pública de Barcelona, Servei de Química, Barcelona, Spain
Muñoz G.:
Laboratori de l'Agència de Salut Pública de Barcelona, Servei de Química, Barcelona, Spain
López M.J.:
Servei d'Avaluació i Mètodes d'Intervenció, Agència de Salut Publica de Barcelona, Lesseps 1, Barcelona, 08023, Spain
CIBER de Epidemiología y Salud Pública, Madrid, Spain
Department of Experimental and Health Science, Universitat Pompeu Fabra (UPF), Barcelona, Spain
Institut d'Investigació Biomèdica Sant Pau (IIB St. Pau), Barcelona, Spain
|